MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

TCH-165

CAS No. : 1446350-60-2

MCE 站：TCH-165

产品活性：TCH-165 是蛋白酶体组装的小分子调节剂，可增加 20S 水平并促进 20S 介导的蛋白质降解。

研究领域：Metabolic Enzyme/Protease

作用靶点：Proteasome

In Vitro: TCH-165 (0.01-10 μM; 72 hours; RPMI8226 and U87MG cells) treatment inhibits cell growth of RPMI8226 and U87MG cells with IC50 of 1.6 μM and 2.4 μM, respectively.
TCH-165 (0-10 μM; 24 hours; HEK293T cells) treatment enhances ODC degradation is blocked by BTZ indicated that this event is proteasome-mediated. TCH-165 enhances proteolytic degradation in a concentration-dependent manner.
TCH-165 enhances the chymotrypsin-like (CT-L), trypsin-like (Tryp-L) and caspase-like (Casp-L) activities with EC₅₀s of 4.2 μM, 3.2 μM and 4.7 μM, respectively.
TCH-165 enhances 20S-mediated degradation of IDPs, α-syn, and tau in vitro, and does not induce the degradation of structured proteins such as GAPDH.
TCH-165-treated cells display a decrease in the assembled 26S and an increase in the 20S proteasome. TCH-165 regulates the dynamic equilibrium between the 20S and 26S proteasome complexes, favoring 20S-mediated protein degradation.

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Ubiquitination Compound Library  |  MG-132  |  Bortezomib  |  Tripterin  |  Pepstatin Trifluoroacetate  |  Epoxomicin  |  MDL-28170  |  Calpeptin  |  MG-101  |  PD150606  |  Aclacinomycin A hydrochloride  |  Gabexate mesylate  |  PD 151746  |  4'-Hydroxychalcone  |  VR23  |  Tomatine  |  Lactacystin  |  18α-Glycyrrhetinic acid  |  (Rac)-Calpain Inhibitor XII  |  (1S,2S)-Bortezomib  |  Acetyl-Calpastatin(184-210)(human)  |  ALLM  |  PR-39  |  PR-924  |  PTP1B-IN-9  |  UK-101

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。